Risankizumab | 1612838-76-2 | Risankizumab rzaa | BI 655066

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Product Overview

Product Name	Risankizumab (Synonyms: Risankizumab rzaa; BI 655066; ABBV-066)
CAS	1612838-76-2
MW	145.92 kDa
Appearance	Colorless to light yellow liquid

Product details

Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd <10 pM) and inhibiting IL-17 production induced by human IL-23 in mouse splenocytes (IC50 = 2 pM). Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1403

Risankizumab (Synonyms: Risankizumab rzaa; BI 655066; ABBV-066)

1612838-76-2 95+%